SlideShare una empresa de Scribd logo
1 de 56
MARCH 2013
                                  WEBINAR
Three Part Series on Advocacy Issues in prep for our advocates.
             - Presented by Camille S. Bonta, MHS
          Principal of Summit Health Care Consulting
Welcome!
      Medicare Cost Sharing for
      Screening Colonoscopy
 Part of Fight Colorectal Cancer’s Monthly Patient Webinar
                       Series – Part 1



www.FightColorectalCancer.org
877-427-2111
Fight Colorectal Cancer
1. Our speaker: Camille Bonta, MHS, Policy Expert

2. Archived webinars: Link.FightCRC.org/Webinars

3. Or call the Fight Colorectal Cancer Answer Line at 877-427-2111




    www.FightColorectalCancer.org
    877-427-2111
Fight Colorectal Cancer




Funding Research Directly
Lisa Dubow Fund
http://fightcolorectalcancer.org/research/lisa-fund
Fight Colorectal Cancer
Disclaimer

The information and services provided by Fight Colorectal Cancer are
for general informational purposes only.

The information and services are not intended to be substitutes for
professional medical advice, diagnosis, or treatment.

If you are ill, or suspect that you are ill, see a doctor immediately. In
an emergency, call 911 or go to the nearest emergency room.

Fight Colorectal Cancer never recommends or endorses any specific
physicians, products or treatments for any condition.

www.FightColorectalCancer.org
877-427-2111
Fight Colorectal Cancer




                 Camille S. Bonta, MHS
       Principal of Summit Health Care Consulting



www.FightColorectalCancer.org
877-427-2111
Medicare Cost Sharing for Screening Colonoscopy



Preparing to Talk with Members of Congress about Cost Barriers to
Colorectal Cancer Screening for Medicare Beneficiaries

Call-on Congress
March 18-20, 2013
Medicare Cost Sharing for Screening Colonoscopy

    • Current Medicare Law
      – Colorectal cancer screenings are free, including
        screening colonoscopy.
      – However, if polyp is removed during
        colonoscopy, Medicare beneficiary must pay
        coinsurance.
      – February 20 Administration communication
        clarifies, under health reform law private
        insurers cannot impose cost sharing for
        screening colonoscopy when polyp is removed.
         • Coinsurance liability persists for Medicare patients.
Medicare Cost Sharing for Screening Colonoscopy

    • Why Current Law Requires Correction
      – Cost sharing creates disincentive to screening.
         • March 2012 study – During recent economic
           recession, insured Americans (age 50-64) reduced
           use of screening colonoscopy.
      – Trends in decreased colorectal cancer
        incidence, but screening rates still lag behind
        the Healthy People 2020 goal of 70.5%.
         • 1 in 3 Americans are not up-to-date with
           recommended screening.
Medicare Cost Sharing for Screening Colonoscopy

    • Key Messages

      – Current Medicare policy is confusing to patients
        and health care providers.
      – Coinsurance “gap” due to unintentional
        oversight in the law.
Medicare Cost Sharing for Screening Colonoscopy

    • Key Messages

       – Screening colonoscopy is the most effective
         test for the prevention of colorectal cancer.
          • Allows for the removal of potentially precancerous
            polyps during the procedure, making it a unique
            preventive service.
          • Medicare pays roughly $600-$1,300 for screening
            colonoscopy (with anesthesia); $300,000 annually to
            treat an advanced case of colorectal cancer.
Medicare Cost Sharing for Screening Colonoscopy

   • Cost Sharing Definitions

      – Deductible: Amount beneficiary has to pay out
        of pocket for expenses before Medicare will
        cover the remaining costs.

      – Coinsurance: Set percentage the beneficiary
        must pay of the covered costs after the
        deductible has been reached.
Medicare Cost Sharing for Screening Colonoscopy

   • Colorectal Cancer Screening Coverage
     and Cost Sharing History

     – 1998: Medicare coverage of screening
       colonoscopy for high-risk individuals.
     – 2001: Medicare coverage of screening
       colonoscopy for average-risk individuals.
Medicare Cost Sharing for Screening Colonoscopy

    • Colorectal Cancer Screening Coverage
      and Cost Sharing History

      – 2006: Deficit Reduction Act waived Medicare
        beneficiary deductible for colorectal cancer
        screening.
         • However, if a polyp was removed during screening
           colonoscopy, beneficiary was liable for the
           deductible.
Medicare Cost Sharing for Screening Colonoscopy

    • Colorectal Cancer Screening Coverage
      and Cost Sharing History

      – 2010: Affordable Care Act corrected previous
        law. Now deductible is always waived, even if a
        polyp is removed during a screening
        colonoscopy.
Medicare Cost Sharing for Screening Colonoscopy

    • Colorectal Cancer Screening Coverage
      and Cost Sharing History

      – 2010: Affordable Care Act waives coinsurance
        for colorectal cancer screenings.
         • Colonoscopy, Sigmoidoscopy, FOBT


      – But, Medicare beneficiary must still pay
        coinsurance if polyp is removed during
        screening colonoscopy.
Medicare Cost Sharing for Screening Colonoscopy

   • Fight Colorectal Cancer’s Request to
     Congress

      – Congressional Action is Needed this Year to
        Correct Coinsurance Gap
         • House and Senate legislation poised for introduction in
           March.
         • Legislation same as 112th Congress - H.R. 4120,
           “Removing Barriers to Colorectal Cancer Screening Act.”
Medicare Cost Sharing for Screening Colonoscopy

    • Parting Words

      – An effective advocate ties their personal story
        with key messages and facts.
      – Colorectal cancer prevention has a history of
        bipartisan support.
      – Despite claims, colorectal cancer screenings
        are not without cost sharing for all Medicare
        beneficiaries.
      – Congress needs to take action this year.
Fight Colorectal Cancer
                               CONTACT US

    Fight Colorectal Cancer
      1414 Prince Street, Suite 204
          Alexandria, VA 22314
             (703) 548-1225
 Toll-Free Answer Line: 1-877-427-2111
     www.FightColorectalCancer.org

Email us: Info@FightColorectalCancer.org
Welcome!
            Supporting Colorectal
              Cancer Research
 Part of Fight Colorectal Cancer’s Monthly Patient Webinar
                       Series – Part 2



www.FightColorectalCancer.org
877-427-2111
Fight Colorectal Cancer
1. Tonight’s speaker: Camille Bonta, MHS, Policy Expert

2. Archived webinars: Link.FightCRC.org/Webinars

3. Or call the Fight Colorectal Cancer Answer Line at 877-427-
2111




   www.FightColorectalCancer.org
   877-427-2111
Fight Colorectal Cancer
Disclaimer

The information and services provided by Fight Colorectal
Cancer are for general informational purposes only.

The information and services are not intended to be substitutes
for professional medical advice, diagnosis, or treatment.

If you are ill, or suspect that you are ill, see a doctor
immediately. In an emergency, call 911 or go to the nearest
emergency room.

Fight Colorectal Cancer never recommends or endorses any
specific physicians, products or treatments for any condition.
www.FightColorectalCancer.org
877-427-2111
Fight Colorectal Cancer




                Camille S. Bonta, MHS
      Principal of Summit Health Care Consulting



www.FightColorectalCancer.org
877-427-2111
Supporting Colorectal Cancer Research


Preparing to Talk with Members of Congress about Funding for
Colorectal Cancer Research

Call-on Congress
March 18-20, 2013
Supporting Colorectal Cancer Research

   • Lawmakers can demonstrate their
     commitment to colorectal cancer
     research by:

     – Providing increased funding for the DoD Peer
       Reviewed Cancer Research Program
       (PRCRP).
     – Funding the National Cancer Institute (NCI).
Supporting Colorectal Cancer Research

   • Key Messages

     – Difficult budget environment lends urgency to
       grassroots advocacy.
     – Millions invested in cancer research to date
       have led to great advances.
     – Cancer incidence will nearly double by 2020.
     – 5-year survival rate for colorectal cancer is now
       67 percent.
     – Now is not the time to pull back on federal
       funding.
DoD Peer Reviewed Cancer Research Program

    • Supports research into specific cancers,
      including colorectal cancer, with relevance
      to military service members.

    • Program is one of several medical
      research programs under the
      Congressionally Directed Medical
      Research Programs (CDMRP).
DoD Peer Reviewed Cancer Research Program

      – Innovative, high-reward research.
      – Supports early-career researchers and
        clinicians.
      – Focused on delivering breakthroughs in
        prevention, detection, and treatment of cancer.
      – Complements, not duplicates, research
        conducted through the National Institutes of
        Health (NIH).
DoD Peer Reviewed Cancer Research Program

    • Funding History

       –   Fiscal Year 2009 - $16 million
       –   Fiscal Year 2010 - $15 million
       –   Fiscal Year 2011 - $16 million
       –   Fiscal Year 2012 - $12.8 million
       –   Fiscal Year 2013 - Continuing Resolution
       –   Fiscal Year 2014 - $16 million (Fight
           Colorectal Cancer Request)
DoD Peer Reviewed Cancer Research Program
     • Colorectal Cancer Funding History

       – Colorectal cancer first included in the PRCRP
         in fiscal year 2010.
       – Fiscal year 2010 – 472 applications; 101 for
         colorectal cancer research.
          • Four colorectal cancer grants funded for total of just
            under $2 million.
       – Fiscal year 2011 – 845 applications; 135 for
         colorectal cancer research.
          • Four colorectal cancer grants funded for total of $1.3
            million.
DoD Peer Reviewed Cancer Research Program
     • Military Relevance
       – Colorectal cancer is one of the most common forms of
         cancer among active duty military personnel.
       – Colorectal cancer screening rates low (58%) among
         military personnel.
       – Service members are exposed to ionizing radiation in the
         field, which increases risk of colorectal cancer.
       – PRCRP-supported research into non-invasive genetic
         urine test for colorectal cancer.
       – PRCRP-supported research on genes associated with
         ionizing radiation sensitivity and resistance.
National Cancer Institute
• National Cancer Institute

  – One of 27 Institutes and Centers at the NIH.
  – Leads a national effort to eliminate the suffering
    and death from cancer.
NIH Appropriations
National Cancer Institute
• Funds critical colorectal cancer research.
• Congressional support for cancer research
  has contributed to the overall reduction in
  cancer incidence and mortality and an
  improved quality of life for survivors.
• Today’s progress in research and promising
  scientific opportunities require a sustained
  commitment from Congress.
  – The Cancer Genome Atlas is studying 20
    different cancers, including CRC, which will lead
    to more targeted and personalized therapies.
National Cancer Institute
• NIH Funding Supports Economic Growth
  – NIH spending in 2011
     • Produced $62.13 billion in new economic activity.
     • 432,094 new jobs.
  – $3.8 billion in funding for the Human Genome
    Project from 1988-2003 resulted in a return on
    investment of $141 in economic output for every $1
    spent.
National Cancer Institute
• Federal government spends through
  the NIH just over $5 billion on cancer
  research annually.

• Annual direct cost of cancer care is
  $158 billion.
National Cancer Institute
• NIH Funding History
  –   Fiscal Year 2011 - $30.388 billion
  –   Fiscal Year 2012 - $30.623 billion
  –   Fiscal Year 2013 – Continuing Resolution
  –   Fiscal Year 2014 - $32.623 billion (Fight Colorectal Cancer
      Request = 6.5% increase)
• NCI Funding History
  –   Fiscal Year 2011 - $5.058 billion
  –   Fiscal Year 2012 - $5.081 billion
  –   Fiscal Year 2013 – Continuing Resolution
  –   Fiscal Year 2014 - $5.349 (Fight Colorectal Cancer Request =
      5.5% increase)
Supporting Colorectal Cancer Research

   • Parting Words
     – An effective advocate ties their personal story
       with key messages and facts.
     – Help lawmakers understand in human terms
       the importance of DoD and NIH medical
       research.
     – We are on the brink of losing the next
       generation of researchers.
     – Cultivate new congressional cancer research
       champions.
Fight Colorectal Cancer
                               CONTACT US

    Fight Colorectal Cancer
      1414 Prince Street, Suite 204
          Alexandria, VA 22314
             (703) 548-1225
 Toll-Free Answer Line: 1-877-427-2111
     www.FightColorectalCancer.org

Email us: Info@FightColorectalCancer.org
Welcome!
    Centers for Disease Control
         and Prevention
    Colorectal Cancer Control
             Program
     Part of Fight Colorectal Cancer’s Monthly Patient
                   Webinar Series – Part 3
www.FightColorectalCancer.org
877-427-2111
Fight Colorectal Cancer
1. Tonight’s speaker: Camille Bonta, MHS, Policy Expert

2. Archived webinars: Link.FightCRC.org/Webinars

3. Or call the Fight Colorectal Cancer Answer Line at 877-427-2111




    www.FightColorectalCancer.org
    877-427-2111
Fight Colorectal Cancer
The information and services provided by Fight Colorectal Cancer are
for general informational purposes only.

The information and services are not intended to be substitutes for
professional medical advice, diagnosis, or treatment.

If you are ill, or suspect that you are ill, see a doctor immediately. In
an emergency, call 911 or go to the nearest emergency room.

Fight Colorectal Cancer never recommends or endorses any specific
physicians, products or treatments for any condition.




www.FightColorectalCancer.org
877-427-2111
Fight Colorectal Cancer




               Camille S. Bonta, MHS
    Principal of Summit Health Care Consulting



www.FightColorectalCancer.org
877-427-2111
Centers for Disease Control and Prevention
   Colorectal Cancer Control Program



Preparing to Talk with Members of Congress about the
CDC Colorectal Cancer Control Program

Call-on Congress
March 18-20, 2013
Colorectal Cancer Control Program
Colorectal Cancer Control Program
  • CRCCP Track Record Since 2009

    – Screened 20,000+ Individuals
    – Identified 50 Cancers
    – Prevented 2,917 Potential Cancers by Polyp
      Removal
Colorectal Cancer Control Program
  • Key Messages

    – Colorectal cancer screening saves lives.
    – Colorectal cancer screening saves costs.
    – The CRCCP should be a national program, not
      just a program limited to 25 states and 4 tribal
      organizations.
    – Fund the CRCCP at $70 million in fiscal year
      2014.
Colorectal Cancer Control Program
   • Recent Federal Funding History

     –   Fiscal Year 2010 - $44.53 million
     –   Fiscal Year 2011 - $43.07 million
     –   Fiscal Year 2012 - $43 million
     –   Fiscal Year 2013 – Continuing Resolution
Colorectal Cancer Control Program
  • Colorectal Cancer Screening Goals
    – Healthy People 2020 – 70.5% national
      screening rate (adults age 50-75), which would
      represent 1,000 additional deaths prevented
      each year.
    – CRCCP – 80% in CRCCP funded states by
      2014.
    – CRC screening rates increased 13% among
      adults from 2002 to 2010.
    – Just under 60% the U.S. population (age 50+)
      is up-to-date with screening. 1 in 3 adults are
      not being screened.
Colorectal Cancer Control Program
  • Colorectal Cancer Incidence and
    Mortality is Decreasing

    – Incidence declining since 2000 – 3.2% per year
      in men and by 2.8% per year in women.
    – Acceleration in the decline has been largely
      attributed to detection and removal of
      precancerous polyps.
    – Mortality also decreasing – 3.1% per year in
      both men and women.
Colorectal Cancer Control Program
   • More Americans have access to colorectal
     cancer screenings without cost sharing.

   • Awareness remains low about why
     colorectal cancer screening at
     recommended intervals is important.

   • CDC Program dedicates a majority of
     funds to education and outreach strategies.
Colorectal Cancer Control Program
  • Fight Colorectal Cancer’s Request to
    Congress

    – Fund the CRCCP at $70 million for fiscal year
      2014.
       • $27 million increase over fiscal year 2012.
       • Allows for nationwide implementation.
Colorectal Cancer Control Program
  • Funding Challenges

    – Difficult federal budget environment.
       • Unresolved fiscal year 2013 spending bill.
       • Sequestration.
           – $350+ million less for CDC this year if sequestration
             occurs.
       • Budget Control Act discretionary spending caps.
           – $1 trillion cut in discretionary spending 2012-2021.
Colorectal Cancer Control Program

  • Parting Words

    – An effective advocate ties their personal story
      with key messages and facts.
    – Don’t be apologetic for asking your lawmaker to
      fund the CRCCP at $70 million.
    – In this fiscal environment, if you ask for it, you
      have a better chance of getting it. If you don’t
      ask for it, you won’t. Or, worse, you may get
      less than what you have now.
Fight Colorectal Cancer
                               CONTACT US

     Fight Colorectal Cancer
       1414 Prince Street, Suite 204
           Alexandria, VA 22314
              (703) 548-1225
  Toll-Free Answer Line: 1-877-427-2111
     www.FightColorectalCancer.org

Email us: Info@FightColorectalCancer.org
If you are unable to attend Call-on
                                            Thank You!
Congress this year, you can still
participate in our advocacy efforts.

Join us on March 20th for our
Congressional Call-in by calling 1-866-
615-3375. You will be connected with
your congressional members – take the
opportunity to explain what it is we need
Congress to do.

Más contenido relacionado

La actualidad más candente

BALKAN MCO 2011 - J. Vermorken - First line treatment of ovarian cancer: surg...
BALKAN MCO 2011 - J. Vermorken - First line treatment of ovarian cancer: surg...BALKAN MCO 2011 - J. Vermorken - First line treatment of ovarian cancer: surg...
BALKAN MCO 2011 - J. Vermorken - First line treatment of ovarian cancer: surg...
European School of Oncology
 
Cco Gi 2008 Cr Slideset
Cco Gi 2008 Cr SlidesetCco Gi 2008 Cr Slideset
Cco Gi 2008 Cr Slideset
Emad El-Nashar
 
New Trends in the Management of Metastatic Prostate Cancer
New Trends in the Management of Metastatic Prostate CancerNew Trends in the Management of Metastatic Prostate Cancer
New Trends in the Management of Metastatic Prostate Cancer
flasco_org
 
Molecular Testing and Tumor Testing: Why is this important?
Molecular Testing and Tumor Testing: Why is this important? Molecular Testing and Tumor Testing: Why is this important?
Molecular Testing and Tumor Testing: Why is this important?
Fight Colorectal Cancer
 
Invasive Lobular Carcinoma: Biology, Treatment, and Future Directions for Res...
Invasive Lobular Carcinoma: Biology, Treatment, and Future Directions for Res...Invasive Lobular Carcinoma: Biology, Treatment, and Future Directions for Res...
Invasive Lobular Carcinoma: Biology, Treatment, and Future Directions for Res...
AmandaRussell40
 

La actualidad más candente (20)

ASCO 2016 Sarcoma Review
ASCO 2016 Sarcoma ReviewASCO 2016 Sarcoma Review
ASCO 2016 Sarcoma Review
 
Tratamiento inicial de cáncer de mama HR+/Her2- metastásico en postmenopáusicas
Tratamiento inicial de cáncer de mama HR+/Her2- metastásico en postmenopáusicasTratamiento inicial de cáncer de mama HR+/Her2- metastásico en postmenopáusicas
Tratamiento inicial de cáncer de mama HR+/Her2- metastásico en postmenopáusicas
 
Triple Negative Breast Cancer and Women of Color (Slide 2)
Triple Negative Breast Cancer and Women of Color (Slide 2)Triple Negative Breast Cancer and Women of Color (Slide 2)
Triple Negative Breast Cancer and Women of Color (Slide 2)
 
2017 ASCO RECAP: The Latest in Colorectal Cancer Research #CRCWebinar
2017 ASCO RECAP: The Latest in Colorectal Cancer Research #CRCWebinar2017 ASCO RECAP: The Latest in Colorectal Cancer Research #CRCWebinar
2017 ASCO RECAP: The Latest in Colorectal Cancer Research #CRCWebinar
 
Goals of Care When Cancer is Chronic - FightCRC Feb 2018 CRCwebinar
Goals of Care When Cancer is Chronic - FightCRC Feb 2018 CRCwebinarGoals of Care When Cancer is Chronic - FightCRC Feb 2018 CRCwebinar
Goals of Care When Cancer is Chronic - FightCRC Feb 2018 CRCwebinar
 
Prostate cancer updates 2021
Prostate cancer updates 2021Prostate cancer updates 2021
Prostate cancer updates 2021
 
BALKAN MCO 2011 - J. Vermorken - First line treatment of ovarian cancer: surg...
BALKAN MCO 2011 - J. Vermorken - First line treatment of ovarian cancer: surg...BALKAN MCO 2011 - J. Vermorken - First line treatment of ovarian cancer: surg...
BALKAN MCO 2011 - J. Vermorken - First line treatment of ovarian cancer: surg...
 
Cco Gi 2008 Cr Slideset
Cco Gi 2008 Cr SlidesetCco Gi 2008 Cr Slideset
Cco Gi 2008 Cr Slideset
 
triple negative breast cancer
triple negative breast cancertriple negative breast cancer
triple negative breast cancer
 
Triple Negative Breast Cancer and Women of Color (Slide 1)
Triple Negative Breast Cancer and Women of Color (Slide 1)Triple Negative Breast Cancer and Women of Color (Slide 1)
Triple Negative Breast Cancer and Women of Color (Slide 1)
 
New Trends in the Management of Metastatic Prostate Cancer
New Trends in the Management of Metastatic Prostate CancerNew Trends in the Management of Metastatic Prostate Cancer
New Trends in the Management of Metastatic Prostate Cancer
 
Tailoring Colorectal Cancer Treatment: Sidedness, Biomarkers - August 2018 CR...
Tailoring Colorectal Cancer Treatment: Sidedness, Biomarkers - August 2018 CR...Tailoring Colorectal Cancer Treatment: Sidedness, Biomarkers - August 2018 CR...
Tailoring Colorectal Cancer Treatment: Sidedness, Biomarkers - August 2018 CR...
 
Survivorship Issues Genetics 2016
Survivorship Issues Genetics 2016Survivorship Issues Genetics 2016
Survivorship Issues Genetics 2016
 
Prostate video 2
Prostate video 2Prostate video 2
Prostate video 2
 
4-yr OS after 2nd-line Nivolumab, pooled analysis (based on Scott Antonia pre...
4-yr OS after 2nd-line Nivolumab, pooled analysis (based on Scott Antonia pre...4-yr OS after 2nd-line Nivolumab, pooled analysis (based on Scott Antonia pre...
4-yr OS after 2nd-line Nivolumab, pooled analysis (based on Scott Antonia pre...
 
Novel biomarkers in ovarian carcinoma
Novel biomarkers in ovarian carcinomaNovel biomarkers in ovarian carcinoma
Novel biomarkers in ovarian carcinoma
 
HTAi 2015 - Cost-effectiveness analysis of bevacizumab and cetuximab in advan...
HTAi 2015 - Cost-effectiveness analysis of bevacizumab and cetuximab in advan...HTAi 2015 - Cost-effectiveness analysis of bevacizumab and cetuximab in advan...
HTAi 2015 - Cost-effectiveness analysis of bevacizumab and cetuximab in advan...
 
Molecular Testing and Tumor Testing: Why is this important?
Molecular Testing and Tumor Testing: Why is this important? Molecular Testing and Tumor Testing: Why is this important?
Molecular Testing and Tumor Testing: Why is this important?
 
DNA Repair Therapies for Ovarian Cancer
DNA Repair Therapies for Ovarian CancerDNA Repair Therapies for Ovarian Cancer
DNA Repair Therapies for Ovarian Cancer
 
Invasive Lobular Carcinoma: Biology, Treatment, and Future Directions for Res...
Invasive Lobular Carcinoma: Biology, Treatment, and Future Directions for Res...Invasive Lobular Carcinoma: Biology, Treatment, and Future Directions for Res...
Invasive Lobular Carcinoma: Biology, Treatment, and Future Directions for Res...
 

Similar a March 2013 webinar congressional advocacy prep

CSC Insight into Patient Access to Care in Cancer
CSC Insight into Patient Access to Care in CancerCSC Insight into Patient Access to Care in Cancer
CSC Insight into Patient Access to Care in Cancer
Bev Soult
 
Fight Colorectal Cancer Who We Are Presentation
Fight Colorectal Cancer Who We Are PresentationFight Colorectal Cancer Who We Are Presentation
Fight Colorectal Cancer Who We Are Presentation
Fight Colorectal Cancer
 
Andrea Dwyyer Call-on Congress panel speaker
Andrea Dwyyer  Call-on Congress panel speakerAndrea Dwyyer  Call-on Congress panel speaker
Andrea Dwyyer Call-on Congress panel speaker
Fight Colorectal Cancer
 
QALYs: What are they and how do they impact patient access to new cancer medi...
QALYs: What are they and how do they impact patient access to new cancer medi...QALYs: What are they and how do they impact patient access to new cancer medi...
QALYs: What are they and how do they impact patient access to new cancer medi...
CanCertainty
 

Similar a March 2013 webinar congressional advocacy prep (20)

Camille Bonta 4 pm Legislative Presentation
Camille Bonta 4 pm Legislative PresentationCamille Bonta 4 pm Legislative Presentation
Camille Bonta 4 pm Legislative Presentation
 
Call-On Congress 2012: Coinsurance Webinar #2
Call-On Congress 2012: Coinsurance Webinar #2Call-On Congress 2012: Coinsurance Webinar #2
Call-On Congress 2012: Coinsurance Webinar #2
 
Fight Colorectal Cancer Legislative & Regulatory 2013 Agenda
Fight Colorectal Cancer Legislative & Regulatory 2013 AgendaFight Colorectal Cancer Legislative & Regulatory 2013 Agenda
Fight Colorectal Cancer Legislative & Regulatory 2013 Agenda
 
Maine’s CRC Policy Story
Maine’s CRC Policy StoryMaine’s CRC Policy Story
Maine’s CRC Policy Story
 
CSC Insight into Patient Access to Care in Cancer
CSC Insight into Patient Access to Care in CancerCSC Insight into Patient Access to Care in Cancer
CSC Insight into Patient Access to Care in Cancer
 
Call-On Congress 2012: CRC research webinar #3
Call-On Congress 2012: CRC research webinar #3Call-On Congress 2012: CRC research webinar #3
Call-On Congress 2012: CRC research webinar #3
 
Health Care: Understanding the Future, a Canadian Perspective by Carolyn Benn...
Health Care: Understanding the Future, a Canadian Perspective by Carolyn Benn...Health Care: Understanding the Future, a Canadian Perspective by Carolyn Benn...
Health Care: Understanding the Future, a Canadian Perspective by Carolyn Benn...
 
Cecily Hall Call-on Congress 2012 Presentation
Cecily Hall Call-on Congress 2012 PresentationCecily Hall Call-on Congress 2012 Presentation
Cecily Hall Call-on Congress 2012 Presentation
 
Fight Colorectal Cancer Who We Are Presentation
Fight Colorectal Cancer Who We Are PresentationFight Colorectal Cancer Who We Are Presentation
Fight Colorectal Cancer Who We Are Presentation
 
CCSN's Ontario Virtual Action Week: COVID-19 and Cancer Care - Wave 2
CCSN's Ontario Virtual Action Week: COVID-19 and Cancer Care - Wave 2CCSN's Ontario Virtual Action Week: COVID-19 and Cancer Care - Wave 2
CCSN's Ontario Virtual Action Week: COVID-19 and Cancer Care - Wave 2
 
Women's Access to Healthcare - Georgia CORE Presentation
Women's Access to Healthcare - Georgia CORE PresentationWomen's Access to Healthcare - Georgia CORE Presentation
Women's Access to Healthcare - Georgia CORE Presentation
 
Andrea Dwyyer Call-on Congress panel speaker
Andrea Dwyyer  Call-on Congress panel speakerAndrea Dwyyer  Call-on Congress panel speaker
Andrea Dwyyer Call-on Congress panel speaker
 
Elevate Leads the Way for a Better Cancer Survivorship Experience For Survivo...
Elevate Leads the Way for a Better Cancer Survivorship Experience For Survivo...Elevate Leads the Way for a Better Cancer Survivorship Experience For Survivo...
Elevate Leads the Way for a Better Cancer Survivorship Experience For Survivo...
 
William R Stern MD ConC2012 Presentation
William R Stern MD ConC2012 PresentationWilliam R Stern MD ConC2012 Presentation
William R Stern MD ConC2012 Presentation
 
1410 prof james raftery nhc2015
1410 prof james raftery nhc20151410 prof james raftery nhc2015
1410 prof james raftery nhc2015
 
QALYs: What are they and how do they impact patient access to new cancer medi...
QALYs: What are they and how do they impact patient access to new cancer medi...QALYs: What are they and how do they impact patient access to new cancer medi...
QALYs: What are they and how do they impact patient access to new cancer medi...
 
Healing Arts - 2014 Annual Cancer Report
Healing Arts - 2014 Annual Cancer ReportHealing Arts - 2014 Annual Cancer Report
Healing Arts - 2014 Annual Cancer Report
 
CCSN Webinar - EAOCRC FINAL [Autosaved].pptx
CCSN Webinar - EAOCRC FINAL [Autosaved].pptxCCSN Webinar - EAOCRC FINAL [Autosaved].pptx
CCSN Webinar - EAOCRC FINAL [Autosaved].pptx
 
NCCN Updates 2014 Guidelines
NCCN Updates 2014 Guidelines NCCN Updates 2014 Guidelines
NCCN Updates 2014 Guidelines
 
Ccc in practice_powerpoint_2
Ccc in practice_powerpoint_2Ccc in practice_powerpoint_2
Ccc in practice_powerpoint_2
 

Más de Fight Colorectal Cancer

Más de Fight Colorectal Cancer (20)

Colorectal Cancer Screening Trends in the U.S.
Colorectal Cancer Screening Trends in the U.S.Colorectal Cancer Screening Trends in the U.S.
Colorectal Cancer Screening Trends in the U.S.
 
August 2020 Webinar Slides
August 2020 Webinar SlidesAugust 2020 Webinar Slides
August 2020 Webinar Slides
 
July 2020 webinar slides
July 2020 webinar slidesJuly 2020 webinar slides
July 2020 webinar slides
 
Managing the Digestive Side Effects of Colorectal Cancer
Managing the Digestive Side Effects of Colorectal CancerManaging the Digestive Side Effects of Colorectal Cancer
Managing the Digestive Side Effects of Colorectal Cancer
 
Indiana’s CRC Policy Story
Indiana’s CRC Policy StoryIndiana’s CRC Policy Story
Indiana’s CRC Policy Story
 
Kentucky’s CRC Policy Story Webinar
Kentucky’s CRC Policy Story WebinarKentucky’s CRC Policy Story Webinar
Kentucky’s CRC Policy Story Webinar
 
Biomarkers: Next Generation Sequencing and Updates on NTRK and ctDNA
Biomarkers: Next Generation Sequencing and Updates on NTRK and ctDNABiomarkers: Next Generation Sequencing and Updates on NTRK and ctDNA
Biomarkers: Next Generation Sequencing and Updates on NTRK and ctDNA
 
Coping After a Colorectal Cancer Diagnosis
Coping After a Colorectal Cancer DiagnosisCoping After a Colorectal Cancer Diagnosis
Coping After a Colorectal Cancer Diagnosis
 
Colorectal Cancer Treatment Side Effects of the Skin webinar
Colorectal Cancer Treatment Side Effects of the Skin webinarColorectal Cancer Treatment Side Effects of the Skin webinar
Colorectal Cancer Treatment Side Effects of the Skin webinar
 
GI ASCO 2020 Recap Webinar
GI ASCO 2020 Recap WebinarGI ASCO 2020 Recap Webinar
GI ASCO 2020 Recap Webinar
 
Conversations About End-of-Life Webinar
Conversations About End-of-Life WebinarConversations About End-of-Life Webinar
Conversations About End-of-Life Webinar
 
Clinical Trial Finder Webinar
Clinical Trial Finder WebinarClinical Trial Finder Webinar
Clinical Trial Finder Webinar
 
Palliative Care 101 Webinar
Palliative Care 101 WebinarPalliative Care 101 Webinar
Palliative Care 101 Webinar
 
Cancer-Related Fatigue Webinar
Cancer-Related Fatigue Webinar Cancer-Related Fatigue Webinar
Cancer-Related Fatigue Webinar
 
August 2019 - Recurrence: What now?
August 2019 - Recurrence: What now?August 2019 - Recurrence: What now?
August 2019 - Recurrence: What now?
 
Research Trends in Exercise and Colorectal Cancer Webinar
Research Trends in Exercise and Colorectal Cancer WebinarResearch Trends in Exercise and Colorectal Cancer Webinar
Research Trends in Exercise and Colorectal Cancer Webinar
 
Post ASCO Webinar 2019
Post ASCO Webinar 2019Post ASCO Webinar 2019
Post ASCO Webinar 2019
 
May 2019 – What You Need to Know About Chemotherapy Induced Neuropathy Webinar
May 2019 – What You Need to Know About Chemotherapy Induced Neuropathy WebinarMay 2019 – What You Need to Know About Chemotherapy Induced Neuropathy Webinar
May 2019 – What You Need to Know About Chemotherapy Induced Neuropathy Webinar
 
May 2019 – Cancer and Trauma Webinar
May 2019 – Cancer and Trauma Webinar May 2019 – Cancer and Trauma Webinar
May 2019 – Cancer and Trauma Webinar
 
April 2019 - Medical Cannabis and Colorectal Cancer Webinar
April 2019 - Medical Cannabis and Colorectal Cancer WebinarApril 2019 - Medical Cannabis and Colorectal Cancer Webinar
April 2019 - Medical Cannabis and Colorectal Cancer Webinar
 

March 2013 webinar congressional advocacy prep

  • 1. MARCH 2013 WEBINAR Three Part Series on Advocacy Issues in prep for our advocates. - Presented by Camille S. Bonta, MHS Principal of Summit Health Care Consulting
  • 2. Welcome! Medicare Cost Sharing for Screening Colonoscopy Part of Fight Colorectal Cancer’s Monthly Patient Webinar Series – Part 1 www.FightColorectalCancer.org 877-427-2111
  • 3. Fight Colorectal Cancer 1. Our speaker: Camille Bonta, MHS, Policy Expert 2. Archived webinars: Link.FightCRC.org/Webinars 3. Or call the Fight Colorectal Cancer Answer Line at 877-427-2111 www.FightColorectalCancer.org 877-427-2111
  • 4. Fight Colorectal Cancer Funding Research Directly Lisa Dubow Fund http://fightcolorectalcancer.org/research/lisa-fund
  • 5. Fight Colorectal Cancer Disclaimer The information and services provided by Fight Colorectal Cancer are for general informational purposes only. The information and services are not intended to be substitutes for professional medical advice, diagnosis, or treatment. If you are ill, or suspect that you are ill, see a doctor immediately. In an emergency, call 911 or go to the nearest emergency room. Fight Colorectal Cancer never recommends or endorses any specific physicians, products or treatments for any condition. www.FightColorectalCancer.org 877-427-2111
  • 6. Fight Colorectal Cancer Camille S. Bonta, MHS Principal of Summit Health Care Consulting www.FightColorectalCancer.org 877-427-2111
  • 7. Medicare Cost Sharing for Screening Colonoscopy Preparing to Talk with Members of Congress about Cost Barriers to Colorectal Cancer Screening for Medicare Beneficiaries Call-on Congress March 18-20, 2013
  • 8. Medicare Cost Sharing for Screening Colonoscopy • Current Medicare Law – Colorectal cancer screenings are free, including screening colonoscopy. – However, if polyp is removed during colonoscopy, Medicare beneficiary must pay coinsurance. – February 20 Administration communication clarifies, under health reform law private insurers cannot impose cost sharing for screening colonoscopy when polyp is removed. • Coinsurance liability persists for Medicare patients.
  • 9. Medicare Cost Sharing for Screening Colonoscopy • Why Current Law Requires Correction – Cost sharing creates disincentive to screening. • March 2012 study – During recent economic recession, insured Americans (age 50-64) reduced use of screening colonoscopy. – Trends in decreased colorectal cancer incidence, but screening rates still lag behind the Healthy People 2020 goal of 70.5%. • 1 in 3 Americans are not up-to-date with recommended screening.
  • 10. Medicare Cost Sharing for Screening Colonoscopy • Key Messages – Current Medicare policy is confusing to patients and health care providers. – Coinsurance “gap” due to unintentional oversight in the law.
  • 11. Medicare Cost Sharing for Screening Colonoscopy • Key Messages – Screening colonoscopy is the most effective test for the prevention of colorectal cancer. • Allows for the removal of potentially precancerous polyps during the procedure, making it a unique preventive service. • Medicare pays roughly $600-$1,300 for screening colonoscopy (with anesthesia); $300,000 annually to treat an advanced case of colorectal cancer.
  • 12. Medicare Cost Sharing for Screening Colonoscopy • Cost Sharing Definitions – Deductible: Amount beneficiary has to pay out of pocket for expenses before Medicare will cover the remaining costs. – Coinsurance: Set percentage the beneficiary must pay of the covered costs after the deductible has been reached.
  • 13. Medicare Cost Sharing for Screening Colonoscopy • Colorectal Cancer Screening Coverage and Cost Sharing History – 1998: Medicare coverage of screening colonoscopy for high-risk individuals. – 2001: Medicare coverage of screening colonoscopy for average-risk individuals.
  • 14. Medicare Cost Sharing for Screening Colonoscopy • Colorectal Cancer Screening Coverage and Cost Sharing History – 2006: Deficit Reduction Act waived Medicare beneficiary deductible for colorectal cancer screening. • However, if a polyp was removed during screening colonoscopy, beneficiary was liable for the deductible.
  • 15. Medicare Cost Sharing for Screening Colonoscopy • Colorectal Cancer Screening Coverage and Cost Sharing History – 2010: Affordable Care Act corrected previous law. Now deductible is always waived, even if a polyp is removed during a screening colonoscopy.
  • 16. Medicare Cost Sharing for Screening Colonoscopy • Colorectal Cancer Screening Coverage and Cost Sharing History – 2010: Affordable Care Act waives coinsurance for colorectal cancer screenings. • Colonoscopy, Sigmoidoscopy, FOBT – But, Medicare beneficiary must still pay coinsurance if polyp is removed during screening colonoscopy.
  • 17. Medicare Cost Sharing for Screening Colonoscopy • Fight Colorectal Cancer’s Request to Congress – Congressional Action is Needed this Year to Correct Coinsurance Gap • House and Senate legislation poised for introduction in March. • Legislation same as 112th Congress - H.R. 4120, “Removing Barriers to Colorectal Cancer Screening Act.”
  • 18. Medicare Cost Sharing for Screening Colonoscopy • Parting Words – An effective advocate ties their personal story with key messages and facts. – Colorectal cancer prevention has a history of bipartisan support. – Despite claims, colorectal cancer screenings are not without cost sharing for all Medicare beneficiaries. – Congress needs to take action this year.
  • 19. Fight Colorectal Cancer CONTACT US Fight Colorectal Cancer 1414 Prince Street, Suite 204 Alexandria, VA 22314 (703) 548-1225 Toll-Free Answer Line: 1-877-427-2111 www.FightColorectalCancer.org Email us: Info@FightColorectalCancer.org
  • 20. Welcome! Supporting Colorectal Cancer Research Part of Fight Colorectal Cancer’s Monthly Patient Webinar Series – Part 2 www.FightColorectalCancer.org 877-427-2111
  • 21. Fight Colorectal Cancer 1. Tonight’s speaker: Camille Bonta, MHS, Policy Expert 2. Archived webinars: Link.FightCRC.org/Webinars 3. Or call the Fight Colorectal Cancer Answer Line at 877-427- 2111 www.FightColorectalCancer.org 877-427-2111
  • 22. Fight Colorectal Cancer Disclaimer The information and services provided by Fight Colorectal Cancer are for general informational purposes only. The information and services are not intended to be substitutes for professional medical advice, diagnosis, or treatment. If you are ill, or suspect that you are ill, see a doctor immediately. In an emergency, call 911 or go to the nearest emergency room. Fight Colorectal Cancer never recommends or endorses any specific physicians, products or treatments for any condition. www.FightColorectalCancer.org 877-427-2111
  • 23. Fight Colorectal Cancer Camille S. Bonta, MHS Principal of Summit Health Care Consulting www.FightColorectalCancer.org 877-427-2111
  • 24. Supporting Colorectal Cancer Research Preparing to Talk with Members of Congress about Funding for Colorectal Cancer Research Call-on Congress March 18-20, 2013
  • 25. Supporting Colorectal Cancer Research • Lawmakers can demonstrate their commitment to colorectal cancer research by: – Providing increased funding for the DoD Peer Reviewed Cancer Research Program (PRCRP). – Funding the National Cancer Institute (NCI).
  • 26. Supporting Colorectal Cancer Research • Key Messages – Difficult budget environment lends urgency to grassroots advocacy. – Millions invested in cancer research to date have led to great advances. – Cancer incidence will nearly double by 2020. – 5-year survival rate for colorectal cancer is now 67 percent. – Now is not the time to pull back on federal funding.
  • 27. DoD Peer Reviewed Cancer Research Program • Supports research into specific cancers, including colorectal cancer, with relevance to military service members. • Program is one of several medical research programs under the Congressionally Directed Medical Research Programs (CDMRP).
  • 28. DoD Peer Reviewed Cancer Research Program – Innovative, high-reward research. – Supports early-career researchers and clinicians. – Focused on delivering breakthroughs in prevention, detection, and treatment of cancer. – Complements, not duplicates, research conducted through the National Institutes of Health (NIH).
  • 29. DoD Peer Reviewed Cancer Research Program • Funding History – Fiscal Year 2009 - $16 million – Fiscal Year 2010 - $15 million – Fiscal Year 2011 - $16 million – Fiscal Year 2012 - $12.8 million – Fiscal Year 2013 - Continuing Resolution – Fiscal Year 2014 - $16 million (Fight Colorectal Cancer Request)
  • 30. DoD Peer Reviewed Cancer Research Program • Colorectal Cancer Funding History – Colorectal cancer first included in the PRCRP in fiscal year 2010. – Fiscal year 2010 – 472 applications; 101 for colorectal cancer research. • Four colorectal cancer grants funded for total of just under $2 million. – Fiscal year 2011 – 845 applications; 135 for colorectal cancer research. • Four colorectal cancer grants funded for total of $1.3 million.
  • 31. DoD Peer Reviewed Cancer Research Program • Military Relevance – Colorectal cancer is one of the most common forms of cancer among active duty military personnel. – Colorectal cancer screening rates low (58%) among military personnel. – Service members are exposed to ionizing radiation in the field, which increases risk of colorectal cancer. – PRCRP-supported research into non-invasive genetic urine test for colorectal cancer. – PRCRP-supported research on genes associated with ionizing radiation sensitivity and resistance.
  • 32. National Cancer Institute • National Cancer Institute – One of 27 Institutes and Centers at the NIH. – Leads a national effort to eliminate the suffering and death from cancer.
  • 34. National Cancer Institute • Funds critical colorectal cancer research. • Congressional support for cancer research has contributed to the overall reduction in cancer incidence and mortality and an improved quality of life for survivors. • Today’s progress in research and promising scientific opportunities require a sustained commitment from Congress. – The Cancer Genome Atlas is studying 20 different cancers, including CRC, which will lead to more targeted and personalized therapies.
  • 35. National Cancer Institute • NIH Funding Supports Economic Growth – NIH spending in 2011 • Produced $62.13 billion in new economic activity. • 432,094 new jobs. – $3.8 billion in funding for the Human Genome Project from 1988-2003 resulted in a return on investment of $141 in economic output for every $1 spent.
  • 36. National Cancer Institute • Federal government spends through the NIH just over $5 billion on cancer research annually. • Annual direct cost of cancer care is $158 billion.
  • 37. National Cancer Institute • NIH Funding History – Fiscal Year 2011 - $30.388 billion – Fiscal Year 2012 - $30.623 billion – Fiscal Year 2013 – Continuing Resolution – Fiscal Year 2014 - $32.623 billion (Fight Colorectal Cancer Request = 6.5% increase) • NCI Funding History – Fiscal Year 2011 - $5.058 billion – Fiscal Year 2012 - $5.081 billion – Fiscal Year 2013 – Continuing Resolution – Fiscal Year 2014 - $5.349 (Fight Colorectal Cancer Request = 5.5% increase)
  • 38. Supporting Colorectal Cancer Research • Parting Words – An effective advocate ties their personal story with key messages and facts. – Help lawmakers understand in human terms the importance of DoD and NIH medical research. – We are on the brink of losing the next generation of researchers. – Cultivate new congressional cancer research champions.
  • 39. Fight Colorectal Cancer CONTACT US Fight Colorectal Cancer 1414 Prince Street, Suite 204 Alexandria, VA 22314 (703) 548-1225 Toll-Free Answer Line: 1-877-427-2111 www.FightColorectalCancer.org Email us: Info@FightColorectalCancer.org
  • 40. Welcome! Centers for Disease Control and Prevention Colorectal Cancer Control Program Part of Fight Colorectal Cancer’s Monthly Patient Webinar Series – Part 3 www.FightColorectalCancer.org 877-427-2111
  • 41. Fight Colorectal Cancer 1. Tonight’s speaker: Camille Bonta, MHS, Policy Expert 2. Archived webinars: Link.FightCRC.org/Webinars 3. Or call the Fight Colorectal Cancer Answer Line at 877-427-2111 www.FightColorectalCancer.org 877-427-2111
  • 42. Fight Colorectal Cancer The information and services provided by Fight Colorectal Cancer are for general informational purposes only. The information and services are not intended to be substitutes for professional medical advice, diagnosis, or treatment. If you are ill, or suspect that you are ill, see a doctor immediately. In an emergency, call 911 or go to the nearest emergency room. Fight Colorectal Cancer never recommends or endorses any specific physicians, products or treatments for any condition. www.FightColorectalCancer.org 877-427-2111
  • 43. Fight Colorectal Cancer Camille S. Bonta, MHS Principal of Summit Health Care Consulting www.FightColorectalCancer.org 877-427-2111
  • 44. Centers for Disease Control and Prevention Colorectal Cancer Control Program Preparing to Talk with Members of Congress about the CDC Colorectal Cancer Control Program Call-on Congress March 18-20, 2013
  • 46. Colorectal Cancer Control Program • CRCCP Track Record Since 2009 – Screened 20,000+ Individuals – Identified 50 Cancers – Prevented 2,917 Potential Cancers by Polyp Removal
  • 47. Colorectal Cancer Control Program • Key Messages – Colorectal cancer screening saves lives. – Colorectal cancer screening saves costs. – The CRCCP should be a national program, not just a program limited to 25 states and 4 tribal organizations. – Fund the CRCCP at $70 million in fiscal year 2014.
  • 48. Colorectal Cancer Control Program • Recent Federal Funding History – Fiscal Year 2010 - $44.53 million – Fiscal Year 2011 - $43.07 million – Fiscal Year 2012 - $43 million – Fiscal Year 2013 – Continuing Resolution
  • 49. Colorectal Cancer Control Program • Colorectal Cancer Screening Goals – Healthy People 2020 – 70.5% national screening rate (adults age 50-75), which would represent 1,000 additional deaths prevented each year. – CRCCP – 80% in CRCCP funded states by 2014. – CRC screening rates increased 13% among adults from 2002 to 2010. – Just under 60% the U.S. population (age 50+) is up-to-date with screening. 1 in 3 adults are not being screened.
  • 50. Colorectal Cancer Control Program • Colorectal Cancer Incidence and Mortality is Decreasing – Incidence declining since 2000 – 3.2% per year in men and by 2.8% per year in women. – Acceleration in the decline has been largely attributed to detection and removal of precancerous polyps. – Mortality also decreasing – 3.1% per year in both men and women.
  • 51. Colorectal Cancer Control Program • More Americans have access to colorectal cancer screenings without cost sharing. • Awareness remains low about why colorectal cancer screening at recommended intervals is important. • CDC Program dedicates a majority of funds to education and outreach strategies.
  • 52. Colorectal Cancer Control Program • Fight Colorectal Cancer’s Request to Congress – Fund the CRCCP at $70 million for fiscal year 2014. • $27 million increase over fiscal year 2012. • Allows for nationwide implementation.
  • 53. Colorectal Cancer Control Program • Funding Challenges – Difficult federal budget environment. • Unresolved fiscal year 2013 spending bill. • Sequestration. – $350+ million less for CDC this year if sequestration occurs. • Budget Control Act discretionary spending caps. – $1 trillion cut in discretionary spending 2012-2021.
  • 54. Colorectal Cancer Control Program • Parting Words – An effective advocate ties their personal story with key messages and facts. – Don’t be apologetic for asking your lawmaker to fund the CRCCP at $70 million. – In this fiscal environment, if you ask for it, you have a better chance of getting it. If you don’t ask for it, you won’t. Or, worse, you may get less than what you have now.
  • 55. Fight Colorectal Cancer CONTACT US Fight Colorectal Cancer 1414 Prince Street, Suite 204 Alexandria, VA 22314 (703) 548-1225 Toll-Free Answer Line: 1-877-427-2111 www.FightColorectalCancer.org Email us: Info@FightColorectalCancer.org
  • 56. If you are unable to attend Call-on Thank You! Congress this year, you can still participate in our advocacy efforts. Join us on March 20th for our Congressional Call-in by calling 1-866- 615-3375. You will be connected with your congressional members – take the opportunity to explain what it is we need Congress to do.